Loading clinical trials...
Loading clinical trials...
Efficacy and Safety of Tocilizumab in the Treatment of Refractory Uveitis in Patients With Behcet's Disease
Conditions
Interventions
Tocilizumab (TCZ)
Locations
1
China
Peking Union Medical College Hospital
Beijing, Beijing Municipality, China
Start Date
May 10, 2018
Primary Completion Date
February 1, 2021
Completion Date
February 1, 2021
Last Updated
March 22, 2021
NCT07218770
NCT06974162
NCT07145008
NCT05486468
NCT05200715
NCT06849908
Lead Sponsor
Wenjie Zheng
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions